Novartis Signs mRNA Deal for About $7.8 Billion With China's Abogen

3-line summary

• Novartis signed an mRNA deal worth about $7.8 billion with China's Abogen, according to an Investing.com report.

This summary is our own processing of the source article; see the source link below for full context.